Global Submucosal Injections Market size is expected to be worth around US$ 4.0 Billion by 2034 from US$ 2.3 Billion in 2024.
St. Luke’s Medical Center – Global City’s Institute of Digestive and Liver Diseases (IDLD) has officially been designated a ...
Global Submucosal Injection Agent Market Size Basic Structure of the Submucosal Injection Agent Market Submucosal injection ...
A.I. VALI aims to improve real-time reporting, clinical feedback and research by linking expert observations directly to ...
A prospective Chinese study shows that a standardized oral contrast-enhanced ultrasound flowchart stages gastric cancer depth ...
3d
Lung and Esophageal Cancer: Screening, Surgical Advances, Robotics and Post-operative Rehabilitation
Lung and esophageal cancers remain among the most lethal thoracic malignancies, largely because both present late. The last ...
Gastric cancer remains one of the world’s most lethal malignancies. According to GLOBOCAN 2022 estimates, stomach cancer ...
This is a story told by an imaginary factory manager, 'Old Man,' who has been watching Olympus factories since the 1990s.
New consensus recommendations by the U.S. Multi-Society Task Force (MSTF) on Colorectal Cancer (CRC) address serrated ...
Multi-physician gastroenterology practices lose $140,000 to $220,000 a year to billing errors, according to medical billing company ProMBS. The company says the losses come mostly from miscoding, not ...
PRV111, a nanoengineered, cisplatin-releasing transmucosal patch, achieved a 95.5% pathologic complete response (pCR) rate in patients with non-invasive oral cancer or high-grade dysplasia (HGD), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results